Compounds > sarcinaxanthin
Page last updated: 2024-11-12

sarcinaxanthin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

sarcinaxanthin: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID10941542
SCHEMBL ID2838709
MeSH IDM0063611

Synonyms (9)

Synonym
11031-47-3
sarcinaxanthin
beta,beta-carotene, 5,5',18,18'-tetradehydro-5,5',6,6'-tetrahydro-2,2'-bis(4-hydroxy-3-methyl-2-butenyl)-, (2r(e),2'r(e),6r,6'r)-
SCHEMBL2838709
(2r,6r,2'r,6'r)-(2,2'-bis(4-hydroxy-3-methyl-2-butenyl)-gamma,gamma-carotene)
dehydrogenans-p439
Q63395818
(2e,2'e)-4,4'-((1r,1'r,3r,3'r)-((1e,3e,5e,7e,9e,11e,13e,15e,17e)-3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaene-1,18-diyl)bis(2,2-dimethyl-4-methylenecyclohexane-3,1-diyl))bis(2-methylbut-2-en-1-ol)
(e)-4-[(1r,3r)-3-[(1e,3e,5e,7e,9e,11e,13e,15e,17e)-18-[(1r,3r)-3-[(e)-4-hydroxy-3-methylbut-2-enyl]-2,2-dimethyl-6-methylidenecyclohexyl]-3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaenyl]-2,2-dimethyl-4-methylidenecyclohexyl]-2-methylbut-2-en-
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Pathways (1)

PathwayProteinsCompounds
sarcinaxanthin diglucoside biosynthesis412

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's7 (100.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.75

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.75 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.83 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.75)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceRelationship StrengthStudiesTrialsClassesRoles
phenyl acetate
phenyl acetate: The ester formed between phenol and acetic acid. Don't confuse with phenylacetic acid derivatives listed under PHENYLACETATES.. phenyl acetate : An acetate ester obtained by the formal condensation of phenol with acetic acid.		2.2110benzenes;
phenyl acetates
glucose, (beta-d)-isomer
beta-D-glucose : D-Glucopyranose with beta configuration at the anomeric centre.. (1->4)-beta-D-glucan : A beta-D-glucan in which the glucose units are connected by (1->4) linkages.. (1->3)-beta-D-glucan : A beta-D-glucan in which the glucose units are connected by (1->3) linkages.		2.0510D-glucopyranoseepitope;
mouse metabolite
singlet oxygen
Singlet Oxygen: An excited state of molecular oxygen generated photochemically or chemically. Singlet oxygen reacts with a variety of biological molecules such as NUCLEIC ACIDS; PROTEINS; and LIPIDS; causing oxidative damages.		2.0510chalcogen;
monoatomic oxygen;
nonmetal atom		macronutrient
lycopene
[no description available]		2.5220acyclic caroteneantioxidant;
plant metabolite
decaprenoxanthin
[no description available]		2.830xanthophyll
ConditionIndicatedRelationship StrengthStudiesTrials